Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Tyndale

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Molecular Psychiatry|January 13, 2006
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapyV Malaiyandi, C Lerman, N L Benowitz, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 3, 2000
Regional and cellular distribution of CYP2D subfamily members in rat brainS Miksys, Y Rao, E M Sellers, et al.
Clinical Pharmacology and Therapeutics|August 13, 2013
Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokersD A Dempsey, G St Helen, P Jacob, et al.
Journal of Clinical Psychopharmacology|February 1, 2000
Cytochrome P450 2D6 and treatment of codeine dependenceM K Romach, S V Otton, G Somer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 1999
Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphanR F Tyndale, Y Li, N Y Li, et al.
Neuropharmacology|March 23, 2000
The influence of an endogenous beta3 subunit on recombinant GABA(A) receptor assembly and pharmacology in WSS-1 cells and transiently transfected HEK293 cellsP A Davies, E B Hoffmann, H J Carlisle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1992
Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6)S V Otton, R F Tyndale, D Wu, et al.
Molecular Pharmacology|July 1, 1991
Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6R F Tyndale, R Sunahara, T Inaba, et al.
Journal of Clinical Psychopharmacology|August 5, 1998
Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot studyL A Zawertailo, H L Kaplan, U E Busto, et al.
Pharmacogenetics|September 10, 1998
Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and CaucasiansK Droll, K Bruce-Mensah, S V Otton, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Molecular Psychiatry|January 13, 2006
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapyV Malaiyandi, C Lerman, N L Benowitz, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 3, 2000
Regional and cellular distribution of CYP2D subfamily members in rat brainS Miksys, Y Rao, E M Sellers, et al.
Clinical Pharmacology and Therapeutics|August 13, 2013
Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokersD A Dempsey, G St Helen, P Jacob, et al.
Journal of Clinical Psychopharmacology|February 1, 2000
Cytochrome P450 2D6 and treatment of codeine dependenceM K Romach, S V Otton, G Somer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 1999
Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphanR F Tyndale, Y Li, N Y Li, et al.
Neuropharmacology|March 23, 2000
The influence of an endogenous beta3 subunit on recombinant GABA(A) receptor assembly and pharmacology in WSS-1 cells and transiently transfected HEK293 cellsP A Davies, E B Hoffmann, H J Carlisle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1992
Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6)S V Otton, R F Tyndale, D Wu, et al.
Molecular Pharmacology|July 1, 1991
Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6R F Tyndale, R Sunahara, T Inaba, et al.
Journal of Clinical Psychopharmacology|August 5, 1998
Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot studyL A Zawertailo, H L Kaplan, U E Busto, et al.
Pharmacogenetics|September 10, 1998
Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and CaucasiansK Droll, K Bruce-Mensah, S V Otton, et al.
Pageof 9